410 related articles for article (PubMed ID: 12502787)
1. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist.
McIntyre TM; Pontsler AV; Silva AR; St Hilaire A; Xu Y; Hinshaw JC; Zimmerman GA; Hama K; Aoki J; Arai H; Prestwich GD
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):131-6. PubMed ID: 12502787
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid induces neointima formation through PPARgamma activation.
Zhang C; Baker DL; Yasuda S; Makarova N; Balazs L; Johnson LR; Marathe GK; McIntyre TM; Xu Y; Prestwich GD; Byun HS; Bittman R; Tigyi G
J Exp Med; 2004 Mar; 199(6):763-74. PubMed ID: 15007093
[TBL] [Abstract][Full Text] [Related]
3. Farnesyl phosphates are endogenous ligands of lysophosphatidic acid receptors: inhibition of LPA GPCR and activation of PPARs.
Liliom K; Tsukahara T; Tsukahara R; Zelman-Femiak M; Swiezewska E; Tigyi G
Biochim Biophys Acta; 2006 Dec; 1761(12):1506-14. PubMed ID: 17092771
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2.
Simon MF; Daviaud D; Pradère JP; Grès S; Guigné C; Wabitsch M; Chun J; Valet P; Saulnier-Blache JS
J Biol Chem; 2005 Apr; 280(15):14656-62. PubMed ID: 15710620
[TBL] [Abstract][Full Text] [Related]
5. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists.
Davies SS; Pontsler AV; Marathe GK; Harrison KA; Murphy RC; Hinshaw JC; Prestwich GD; Hilaire AS; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 2001 May; 276(19):16015-23. PubMed ID: 11279149
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid activates peroxisome proliferator activated receptor-γ in CHO cells that over-express glycerol 3-phosphate acyltransferase-1.
Stapleton CM; Mashek DG; Wang S; Nagle CA; Cline GW; Thuillier P; Leesnitzer LM; Li LO; Stimmel JB; Shulman GI; Coleman RA
PLoS One; 2011 Apr; 6(4):e18932. PubMed ID: 21533082
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.
Bandoh K; Aoki J; Hosono H; Kobayashi S; Kobayashi T; Murakami-Murofushi K; Tsujimoto M; Arai H; Inoue K
J Biol Chem; 1999 Sep; 274(39):27776-85. PubMed ID: 10488122
[TBL] [Abstract][Full Text] [Related]
8. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid signaling regulates the KLF9-PPARγ axis in human induced pluripotent stem cell-derived neurons.
Tsukahara T; Yamagishi S; Matsuda Y; Haniu H
Biochem Biophys Res Commun; 2017 Sep; 491(1):223-227. PubMed ID: 28716732
[TBL] [Abstract][Full Text] [Related]
10. Neurotransmitter release from lysophosphatidic acid stimulated PC12 cells: involvement of lysophosphatidic acid receptors.
Shiono S; Kawamoto K; Yoshida N; Kondo T; Inagami T
Biochem Biophys Res Commun; 1993 Jun; 193(2):667-73. PubMed ID: 8390248
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.
Li AC; Brown KK; Silvestre MJ; Willson TM; Palinski W; Glass CK
J Clin Invest; 2000 Aug; 106(4):523-31. PubMed ID: 10953027
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid induces human natural killer cell chemotaxis and intracellular calcium mobilization.
Jin Y; Knudsen E; Wang L; Maghazachi AA
Eur J Immunol; 2003 Aug; 33(8):2083-9. PubMed ID: 12884281
[TBL] [Abstract][Full Text] [Related]
13. Lysophospholipid-Related Diseases and PPARγ Signaling Pathway.
Tsukahara T; Matsuda Y; Haniu H
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258184
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
[TBL] [Abstract][Full Text] [Related]
15. Edg-2/Vzg-1 couples to the yeast pheromone response pathway selectively in response to lysophosphatidic acid.
Erickson JR; Wu JJ; Goddard JG; Tigyi G; Kawanishi K; Tomei LD; Kiefer MC
J Biol Chem; 1998 Jan; 273(3):1506-10. PubMed ID: 9430689
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid-induced arterial wall remodeling: requirement of PPARgamma but not LPA1 or LPA2 GPCR.
Cheng Y; Makarova N; Tsukahara R; Guo H; Shuyu E; Farrar P; Balazs L; Zhang C; Tigyi G
Cell Signal; 2009 Dec; 21(12):1874-84. PubMed ID: 19709640
[TBL] [Abstract][Full Text] [Related]
17. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
[TBL] [Abstract][Full Text] [Related]
18. LPA modulates monocyte migration directly and via LPA-stimulated endothelial cells.
Gustin C; Van Steenbrugge M; Raes M
Am J Physiol Cell Physiol; 2008 Oct; 295(4):C905-14. PubMed ID: 18632732
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid receptor signaling in mammalian retinal pigment epithelial cells.
Thoreson WB; Ryan JS; Shi C; Kelly ME; Bryson EJ; Toews ML; Ediger TL; Chacko DM
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2450-61. PubMed ID: 12091450
[TBL] [Abstract][Full Text] [Related]
20. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex.
Hecht JH; Weiner JA; Post SR; Chun J
J Cell Biol; 1996 Nov; 135(4):1071-83. PubMed ID: 8922387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
